Lifecore Biomedical Inc
NASDAQ:LFCR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Lifecore Biomedical Inc
NASDAQ:LFCR
|
US |
|
E
|
Everland Group JSC
VN:EVG
|
VN |
|
Loyal Lithium Ltd
ASX:LLI
|
AU |
|
Microbix Biosystems Inc
TSX:MBX
|
CA |
|
H
|
Harsco Corp
F:HA7
|
US |
|
NanoXplore Inc
TSX:GRA
|
CA |
|
Panoramic Resources Ltd
ASX:PAN
|
AU |
|
Y
|
Yamini Investments Company Ltd
BSE:511012
|
IN |
|
Decisive Dividend Corp
XTSX:DE
|
CA |
|
Kaival Brands Innovations Group Inc
NASDAQ:KAVL
|
US |
|
Indofood Agri Resources Ltd
SGX:5JS
|
SG |
|
C
|
CCL Industries Inc
TSX:CCL.B
|
CA |
|
I-Mab
NASDAQ:IMAB
|
CN |
Wall Street
Price Targets
LFCR Price Targets Summary
Lifecore Biomedical Inc
According to Wall Street analysts, the average 1-year price target for
LFCR
is 8.93 USD
with a low forecast of 7.58 USD and a high forecast of 10.5 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is LFCR's stock price target?
Price Target
8.93
USD
According to Wall Street analysts, the average 1-year price target for
LFCR
is 8.93 USD
with a low forecast of 7.58 USD and a high forecast of 10.5 USD.
What is Lifecore Biomedical Inc's Revenue forecast?
Projected CAGR
7%
For the last 13 years the
compound annual growth rate for
Lifecore Biomedical Inc's revenue is
-7%.
The projected
CAGR
for the next 4 years is
7%.
